Leukemia Recurrence Exclusively in the Breast after Stem Cell Transplant
نویسندگان
چکیده
منابع مشابه
Stem Cell in Breast Milk
Tissue-engineered biomaterials have existed approximately 40 years as simple biomimetic structures. Replacement of human tissue with new tissue can be accomplished by generating replacements outside of the body or in situ in the body. In each case, the key elements are described as the tissue engineering triad of scaffolds, cells, and signals. Scaffolds can be produced synthetically or derived ...
متن کاملDisseminated Bocavirus Infection after Stem Cell Transplant
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 9, September 2007 1425 the patient 3 days before she died, a friend and a healthcare worker had contact with her on the day before her death, and the rest of the healthcare workers had contact with the patient on the day she died. To our knowledge, this is the fi rst imported case and the tenth case of HPS reported in British Columbi...
متن کاملOsteoporosis after stem cell transplantation
Background Stem cell transplantation has become as a novel treatment for end-stage kidney, lung, heart , liver diseases and several hematologic disorders. Improved survival of transplant recipients has raised awareness of post-transplant complications. One of these complications is transplant-related osteoporosis. Methods In this manuscript we review prevention methods for transplant-relat...
متن کاملTHE INCIDENCE OF FEBRILE CONVULSION IN EXCLUSIVELY BREAST-FED CHILDREN
Background: Febrile convulsion (FC) is one of the most common emergency diseases in childhood that has an incidence of3-4%. The most common causes ofFC are gastroenteritis and respiratory infections. We know that exclusive breast-feeding in the first 6 months oflife decreases this disorder. Methods: In this study we evaluated the frequency of exclusive breast-feeding on children who had FC...
متن کاملRandomized study of filgrastim versus molgramostim after peripheral stem cell transplant in breast cancer.
BACKGROUND AND OBJECTIVE The aim of this study was to compare the efficacy and toxicity of Filgrastrim (granulocyte colony-stimulating factor-G-CSF) versus molgramostim (granulomonocyte colony-stimulating factor-GM-CSF) after autologous peripheral blood stem cell transplant (PBSCT) in patients with breast cancer. To the best of our knowledge no randomized studies comparing filgrastrim and molgr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Molecular and Clinical Medicine
سال: 2018
ISSN: 2515-8260
DOI: 10.5334/ejmcm.255